The KomIT research platform will perform several proof-of-concept studies with the overall objectives to i) optimise the different modules of the infrastructure, and ii) generate new knowledge on the beta-cell protective function of either allosteric modulators of the GABA receptor, or antagonists of the NMDA receptor. This research is driven by recent findings of potential beta-cell replacement in response to pharmacological treatment in animal models.